Candid Therapeutics Funding: $370M Raised, Series A (2024)

Candid Therapeutics funding overview

Candid Therapeutics is a Biotech company based in San Diego. Candid Therapeutics has raised $370M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in September 2024. The round record for Candid Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Venrock Healthcare Capital Partners, Fairmount, TCGX, venBio Partners, Foresite Capital, Third Rock Ventures and 1 others. 7 distinct backers are named across the disclosed rounds.

Candid Therapeutics at a glance

Total raised: $370M
Latest round: Series A
Latest round date: September 2024
Industry: Biotech
Headquarters: San Diego
Notable investors: Venrock Healthcare Capital Partners, Fairmount, TCGX, venBio Partners, Foresite Capital, Third Rock Ventures, Fidelity Management

Frequently asked about Candid Therapeutics funding

How much has Candid Therapeutics raised?: Candid Therapeutics has raised $370M in total disclosed funding across the rounds on record.
Who has invested in Candid Therapeutics?: Venrock Healthcare Capital Partners, Fairmount, TCGX, venBio Partners, Foresite Capital, Third Rock Ventures are named among the investors backing Candid Therapeutics.
What was the latest Candid Therapeutics funding round?: The most recent disclosed round is a Series A, announced in September 2024.
Where is Candid Therapeutics based?: Candid Therapeutics is based in San Diego.
What sector does Candid Therapeutics operate in?: Candid Therapeutics is tracked under Biotech from San Diego, with $370M in disclosed funding.
When did Candid Therapeutics last raise?: The last disclosed Candid Therapeutics round closed in September 2024 at Series A.

Round data for Candid Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in San Diego and backer lists below.

Candid Therapeutics Funding: $370M Raised, Series A (2024)

Candid Therapeutics funding overview

Candid Therapeutics at a glance

Frequently asked about Candid Therapeutics funding

Companies related to Candid Therapeutics (40)

Browse related funding lists (11)